High materiality7/10
UBS Reiterates Buy Rating on Nurix (NRIX)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS reiterates Buy on Nurix with a target of $23; current price around $15.07.
- Target $23; price $15.07; upside ~53%.
Key facts
- 01
Target: $23
- 02
Posted price: $15.07
- 03
Analyst firm: UBS
- 04
Analyst: David Dai
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.